Self-medication and use of medicinal plants among university students in the Peruvian Amazon during the first wave by COVID-19
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.154.1545Keywords:
Self-medication, coronavirus Infections, COVID-19, universities, medicinal plants, PeruAbstract
Introduction: The accelerated spread of SARS-CoV-2 brought about a worldwide crisis, and a series of studies and recommendations to manage it. Before the pandemic, studies evidence a high prevalence of self-medication in university students. Objective: To identify the frequency and characteristics of self-medication against COVID-19 with drugs and/or medicinal plants in students of the National University of the Peruvian Amazon (UNAP), Iquitos, Loreto-Peru, during the first wave of COVID-19. Material and Methods: A descriptive cross-sectional study was conducted on 338 students using a semi-structured ad-hoc survey with questions distributed in 3 dimensions: sociodemographic characteristics, characteristics of COVID-19, and characteristics of the use of drugs/medicinal plants. Results: The mean age was 22.39 years (SD ± 5.59), female sex predominated with 61.2 % (n=207), and 55.3 % (n=187) presented symptoms suggestive of COVID-19. In addition, 76.9% (n=260) used medication, distributed from highest to lowest 65.4% (n=170) drugs and plants, 25.8% (n=67) only plants, and 8.8% (n=23) only drugs; 79.2% (n=206) used self-medication. The main drugs used were dexamethasone, paracetamol, azithromycin, and ivermectin. The main medicinal plants used were eucalyptus, kion, chamomile, and matico. There was a probable association between self-medication and a history of symptoms suggestive of COVID-19 (p=0.001, 95% CI), and COVID-19 contact (p=0.011, 95% CI). Conclusion: Among students of a university in the Peruvian Amazon, a high prevalence and factors associated with self-medication with drugs and medicinal plants were identified.
Downloads
Metrics
References
World Health Organization (WHO). Actualización epidemiológica semanal sobre COVID-19 - 29 de junio de 2021 [Internet]. [cited 2021 Dec 1]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---29-june-2021
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 2020 Jun 1;178:104787.
Campos DM de O, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies. Journal of Evidence-Based Medicine. 2020;13(4):255–60.
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA - Journal of the American Medical Association. 2020;323(18):1824–36.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Kotfis K, Ghavami S, et al. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Vol. 53, Drug Resistance Updates. Churchill Livingstone; 2020. p. 100719.
Zhang HT, Huang MX, Liu X, Zheng XC, Li XH, Chen GQ, et al. Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study. American Journal of Chinese Medicine. 2020;48(4):779–92.
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. New England Journal of Medicine. 2020;1–11.
Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients with Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 2020;324(13):1307–16.
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine. 2020;383(19):1813–26.
Meregildo-Rodriguez ED, Guzmán-Aguilar WM, Vásquez-Tirado GA, Peña-Quispe C. Efecto de los Corticoides Parenterales en la Mortalidad por Covid-19 Severo. Revista del Cuerpo Médico del HNAAA. 2021 Feb 19;13(4):836–394.
World Health Organization (WHO). COVID-19 vaccines [Internet]. [cited 2021 Apr 13]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
World Health Organization. Guidelines for the regulatory assessment of medicinal products for use in self-medication. World Health Organization; 2000. p. WHO/EDM/QSM/00.1.
Hughes CM, McElnay JC, Fleming GF. Benefits and Risks of Self Medication. Drug Safety [Internet]. 2001;24(14):1027–37. Available from: https://doi.org/10.2165/00002018-200124140-00002
Montastruc JL, Bondon-Guitton E, Abadie D, Lacroix I, Berreni A, Pugnet G, et al. Pharmacovigilance, risks and adverse effects of self-medication. Therapies. 2016;71(2):257–62.
Urrunaga-Pastor D, Benites-Zapata VA, Mezones-Holguín E. Factors associated with self-medication in users of drugstores and pharmacies in Peru: An analysis of the national survey on user satisfaction of health services, ENSUSALUD 2015. F1000Res. 2020;8.
Hermoza-Moquillaza R, Loza-Munarriz C, Rodríguez-Hurtado D, Arellano-Sacramento C, Hermoza-Moquillaza V. Automedicación en un distrito de Lima Metropolitana, Perú. Revista Medica Herediana. 2016;27(1):15.
Pillaca Medina ML, Carrión Domínguez K. Automedicación en personas adultas que acuden a boticas del Distrito Jesús Nazareno, Ayacucho 2015. Anales de la Facultad de Medicina. 2016;77(4):387.
Rojas-Adrianzén C, Pereyra-Elías R, Mayta-Tristán P. Prevalence and factors associated with over-the-counter antimicrobial purchases, Peru 2016. Revista Peruana de Medicina Experimental y Salud Publica [Internet]. 2018 Jul 1 [cited 2021 Mar 22];35(3):400–8. Available from: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342018000300005&lng=es&nrm=iso&tlng=es
Corrêa Da Silva MG, Soares MCF, Muccillo-Baisch AL. Self-medication in university students from the city of Rio Grande, Brazil. BMC Public Health [Internet]. 2012;12(1):1. Available from: http://www.biomedcentral.com/1471-2458/12/1471-2458-12-339
Vera-Romero OE, Urcia-Peláez JMM, Ayala-Bravo E, Falla-Aldana BS, Díaz-Vélez C. The Automedication in the students of the National University of the Lambayeque Region during the period November, 2010 – December, 2012. Revista del Cuerpo Médico del HNAAA. 2016;9(1):20–31.
Iuras A, Franco Marques AA, da Fonseca Roberti Garcia L, Santiago MB, Lima Santana LK. Prevalência da automedicação entre estudantes da Universidade do Estado do Amazonas (Brasil). Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial [Internet]. 2016;57(2):104–11. Available from: http://dx.doi.org/10.1016/j.rpemd.2016.01.001
Altamirano Orellana V, Hauyón González K, Mansilla Cerda E, Matamala Muñoz F, Morales Ojeda I, Maury-Sintjago E, et al. Automedicación en estudiantes de una residencia universitaria en Chillán, Chile. Revista Cubana de Salud Pública. 2019;45(1):e1189.
Alshahrani SM, Alavudeen SS, Alakhali KM, Al-Worafi YM, Bahamdan AK, Vigneshwaran E. Self-medication among king khalid university students, Saudi Arabia. Risk Management and Healthcare Policy. 2019;12:243–9.
Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, et al. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study. Journal of Infection [Internet]. 2020;80(6):e1–13. Available from: https://doi.org/10.1016/j.jinf.2020.03.006
Zhao HJ, Lu XX, Deng Y bin, Tang YJ, Lu JC. COVID-19: Asymptomatic carrier transmission is an underestimated problem. Epidemiology and Infection. 2020;4–6.
Furukawa NW, Furukawa NW, Brooks JT, Sobel J. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 while Presymptomatic or Asymptomatic. Emerging Infectious Diseases. 2020;26(7):E1–6.
Álvarez-Antonio C, Meza-Sánchez G, Calampa C, Casanova W, Carey C, Alava F, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. The Lancet Global Health. 2021 Jul 1;9(7):e925–31.
DIRESA LORETO - Portada Principal [Internet]. [cited 2021 Dec 1]. Available from: https://www.diresaloreto.gob.pe/reporte_covid
Welz AN, Emberger-Klein A, Menrad K. The importance of herbal medicine use in the German health-care system: Prevalence, usage pattern, and influencing factors. BMC Health Services Research. 2019 Dec 10;19(1).
Sahib AS, Redha NA, Rasheed RR, Hussain FS. Perception, Attitudes and Knowledge among Medical, Dental, Pharmacy and Nursing Students towards the Use of Herbal Medicine in Iraq. PONTE International Scientific Researchs Journal. 2018;74(6).
Faqihi AHMA, Sayed SF. Self-medication practice with analgesics (NSAIDs and acetaminophen), and antibiotics among nursing undergraduates in University College Farasan Campus, Jazan University, KSA. Annales Pharmaceutiques Francaises [Internet]. 2020; Available from: https://doi.org/10.1016/j.pharma.2020.10.012
Mandal NK, Rauniyar GP, Rai DS, Panday DR, Kushwaha RP, Agrawal SK, et al. Self-medication practice of antibiotics among medical and dental undergraduate students in a medical college in eastern Nepal: A descriptive cross-sectional study. Journal of the Nepal Medical Association. 2020;58(225):328–32.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clinical Microbiology and Infection [Internet]. 2021;27(1):19–27. Available from: https://doi.org/10.1016/j.cmi.2020.08.022
World Health Organization (WHO). Therapeutics and COVID-19: living guideline [Internet]. [cited 2021 Apr 9]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2021.1
Loya AM, González-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: A descriptive, questionnaire-based study. Drugs and Aging. 2009;26(5):423–36.
Aguirre LG, Pereyra-Aguilar P, Silva-Arrieta-Ontaneda I, Alarcón-Urbina M, Palacios-Quintana M, Medina-Salazar H, et al. Consumo de plantas medicinais pelos utentes do “Centro Integral del Adulto Mayor” de La Punta-Callao (Perú). Revista de Fitoterapia. 2016;16(2):165–75.
Alyami HS, Orabi MAA, Aldhabbah FM, Alturki HN, Aburas WI, Alfayez AI, et al. Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia. Saudi Pharmaceutical Journal [Internet]. 2020;28(11):1326–32. Available from: https://doi.org/10.1016/j.jsps.2020.08.023
Hwang JH, Cho HJ, Im H bin, Jung YS, Choi SJ, Han D. Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study. BMC Complement Med Ther. 2020;20(1):147.
Zhang Y, Li Y, Wang X, Qu R, Li J, Li T, et al. Herbal plants coordinate covid-19 in multiple dimensions – An insight analysis for clinically applied remedies. International Journal of Medical Sciences. 2020;17(18):3125–45.
Joshi A, Sunil Krishnan G, Kaushik V. Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses. Journal of Genetic Engineering and Biotechnology. 2020;18(1):0–7.
Thuy BTP, My TTA, Hai NTT, Hieu LT, Hoa TT, Thi Phuong Loan H, et al. Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil. ACS Omega. 2020;5(14):8312–20.
Donma MM, Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Medical Hypotheses [Internet]. 2020;144(May):109934. Available from: https://doi.org/10.1016/j.mehy.2020.109934
Sen D, Debnath P, Debnath B, Bhaumik S, Debnath S. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. Journal of Biomolecular Structure and Dynamics [Internet]. 2020;0(0):1–22. Available from: https://doi.org/10.1080/07391102.2020.1819883
Yepes-Pérez AF, Herrera-Calderon O, Quintero-Saumeth J. Uncaria tomentosa (cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling. Journal of Biomolecular Structure and Dynamics [Internet]. 2020;0(0):1–17. Available from: https://doi.org/10.1080/07391102.2020.1837676
Schnitzler P, Koch C, Reichling J. Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrobial Agents and Chemotherapy. 2007;51(5):1859–62.
Koch C, Reichling J, Schneele J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2008;15(1–2):71–8.
Kaushik S, Jangra G, Kundu V, Yadav JP, Kaushik S. Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. VirusDisease [Internet]. 2020;31(3):270–6. Available from: https://doi.org/10.1007/s13337-020-00584-0
Bhaskar A, Kumari A, Singh M, Kumar S, Kumar S, Dabla A, et al. [6]-Gingerol exhibits potent anti-mycobacterial and immunomodulatory activity against tuberculosis. International Immunopharmacology [Internet]. 2020;87(July):106809. Available from: https://doi.org/10.1016/j.intimp.2020.106809
Gilles M, Zhao J, An M, Agboola S. Chemical composition and antimicrobial properties of essential oils of three Australian Eucalyptus species. Food Chemistry [Internet]. 2010;119(2):731–7. Available from: http://dx.doi.org/10.1016/j.foodchem.2009.07.021
Zhou ZL, Yin WQ, Zou XP, Huang DY, Zhou CL, Li LM, et al. Flavonoid glycosides and potential antivirus activity of isolated compounds from the leaves of Eucalyptus citriodora. J Korean Soc Appl Biol Chem. 2014;57(6):813–7.
Lin SQ, Zhou ZL, Yin WQ. Three new polyphenolic acids from the leaves of Eucalyptus citriodora with antivirus activity. Chemical and Pharmaceutical Bulletin. 2016;64(11):1641–6.
Brochot A, Guilbot A, Haddioui L, Roques C. Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen. 2017;6(4):1–6.
Sadat Sadatrasul M, Fiezi N, Ghasemian N, Shenagari M, Esmaeili S, Ollah Jazaeri E, et al. Oil-in-water emulsion formulated with eucalyptus leaves extract inhibit influenza virus binding and replication in vitro. AIMS Microbiology. 2017;3(4):899–907.
Okba MM, el Gedaily RA, Ashour RM. UPLC–PDA–ESI–qTOF-MS profiling and potent anti-HSV-II activity of Eucalyptus sideroxylon leaves. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences [Internet]. 2017;1068–1069(October):335–42. Available from: http://dx.doi.org/10.1016/j.jchromb.2017.10.065
Brezáni V, Leláková V, Hassan STS, Berchová-Bímová K, Nový P, Klouček P, et al. Anti-infectivity against herpes simplex virus and selected microbes and anti-inflammatory activities of compounds isolated from Eucalyptus globulus labill. Viruses. 2018;10(7).
Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień ME, Zielinska-Pukos MA. Dietary supplements during covid-19 outbreak. Results of google trends analysis supported by plifecovid-19 online studies. Nutrients. 2021;13(1):1–17.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. International Forum of Allergy and Rhinology. 2020;10(7):806–13.
Izquierdo-Domínguez A, Rojas-Lechuga MJ, Chiesa-Estomba C, Calvo-Henríquez C, Ninchritz-Becerra E, Soriano-Reixach M, et al. Smell and taste dysfunction in covid-19 is associated with younger age in ambulatory settings: A multicenter cross-sectional study. Journal of Investigational Allergology and Clinical Immunology. 2020;30(5):346–57.
Tham AC, Thein TL, Lee CS, Tan GSE, Manauis CM, Siow JK, et al. Olfactory taste disorder as a presenting symptom of COVID-19: a large single-center Singapore study. European Archives of Oto-Rhino-Laryngology [Internet]. 2020;(March). Available from: https://doi.org/10.1007/s00405-020-06455-0
Lee DJ, Lockwood J, Das P, Wang R, Grinspun E, Lee JM. Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019. Canadian Journal of Emergency Medicine. 2020;22(5):595–602.
Zahra SA, Iddawela S, Pillai K, Choudhury RY, Harky A. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19? Brain and Behavior. 2020;10(11):1–18.
Petrocelli M, Ruggiero F, Baietti AM, Pandolfi P, Salzano G, Salzano FA, et al. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: The Bologna experience of 300 cases. Journal of Laryngology and Otology. 2020;134(7):571–6.
Araia ZZ, Gebregziabher NK, Mesfun AB. Self medication practice and associated factors among students of Asmara College of Health Sciences, Eritrea: A cross sectional study. Journal of Pharmaceutical Policy and Practice. 2019 Feb 19;12(1).
Zeru N, Fetene D, Geberu DM, Melesse AW, Atnafu A. Self-medication practice and associated factors among university of gondar college of medicine and health sciences students: A cross-sectional study. Patient Preference and Adherence. 2020;14:1779–90.
Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community Transmission of Severe Acute Respiratory. Emerging Infectious Diseases. 2020;26(6):1320–3.
Al-Tawfiq JA, Rodriguez-Morales AJ. Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19). J Hosp Infect [Internet]. 2020;105(2):111–2. Available from: https://doi.org/10.1016/j.jhin.2020.04.002
Gupta L, Gasparyan AY, Misra DP, Agarwal V, Zimba O, Yessirkepov M. Information and misinformation on COVID-19: A cross-sectional survey study. Journal of Korean Medical Science. 2020;35(27):1–11.
Mejia CR. Percepción de miedo o exageración que transmiten los medios de comunicación en la población peruana durante la pandemia de la COVID–19. Revista Cubana de Investigaciones Biomédicas [Internet]. 2020;39(2):1–20. Available from: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/698
Organización Mundial de la Salud. Estrategia de la OMS sobre medicina tradicional 2014-2023. Organización Mundial de la Salud; 2013.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Piero Pasache Pinedo, Maxzy Andrea Diaz Mena, Milagros Flórez Vela, Alberto Salazar Granara
This work is licensed under a Creative Commons Attribution 4.0 International License.
